Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693298011 | Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693300011 | Fusidic acid 20 mg/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4595781000052110 | fusidinsyra 20 milligram/gram, kutan gel | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | fusidinsyra för lokalt bruk | false | Inferred relationship | Some | ||
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has active ingredient | Fusidic acid (substance) | false | Inferred relationship | Some | ||
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Fusidic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Fusidic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | har täljarvärde för koncentrationsstyrka | 20 | false | Inferred relationship | Some | 1 | |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Fusidic acid only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR